[HTML][HTML] ATM and ATR as therapeutic targets in cancer

AM Weber, AJ Ryan - Pharmacology & therapeutics, 2015 - Elsevier
In order to maintain genomic stability, cells have developed sophisticated signalling
pathways to enable DNA damage or DNA replication stress to be resolved. Key mediators of …

[HTML][HTML] Progress towards a clinically-successful ATR inhibitor for cancer therapy

FM Barnieh, PM Loadman, RA Falconer - Current research in …, 2021 - Elsevier
The DNA damage response (DDR) is now known to play an important role in both cancer
development and its treatment. Targeting proteins such as ATR (Ataxia telangiectasia …

Discovery and characterization of AZD6738, a potent inhibitor of ataxia telangiectasia mutated and Rad3 related (ATR) kinase with application as an anticancer agent

KM Foote, JWM Nissink, T McGuire, P Turner… - 2018 - ACS Publications
The kinase ataxia telangiectasia mutated and rad3 related (ATR) is a key regulator of the
DNA-damage response and the apical kinase which orchestrates the cellular processes that …

Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein …

KM Foote, K Blades, A Cronin, S Fillery… - Journal of medicinal …, 2013 - ACS Publications
ATR is an attractive new anticancer drug target whose inhibitors have potential as chemo-or
radiation sensitizers or as monotherapy in tumors addicted to particular DNA-repair …

Targeting ATR in DNA damage response and cancer therapeutics

E Fokas, R Prevo, EM Hammond, TB Brunner… - Cancer treatment …, 2014 - Elsevier
The ataxia telangiectasia and Rad3-related (ATR) plays an important role in maintaining
genome integrity during DNA replication through the phosphorylation and activation of Chk1 …

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer

NJ Curtin - British journal of pharmacology, 2013 - Wiley Online Library
The DNA damage response (DDR), consisting of an orchestrated network of proteins
effecting repair and signalling to cell cycle arrest, to allow time to repair, is essential for cell …

Drugging ATR: progress in the development of specific inhibitors for the treatment of cancer

KM Foote, A Lau, JW M Nissink - Future medicinal chemistry, 2015 - Taylor & Francis
In this article, we review the ATR inhibitor field from initial pharmacological tools to first-
generation clinical candidates with the potential to bring benefit to cancer patients. ATR is a …

Novel Cellular functions of ATR for therapeutic targeting: embryogenesis to Tumorigenesis

H Biswas, Y Makinwa, Y Zou - International Journal of Molecular Sciences, 2023 - mdpi.com
The DNA damage response (DDR) is recognized as having an important role in cancer
growth and treatment. ATR (ataxia telangiectasia mutated and Rad3-related) kinase, a major …

[HTML][HTML] Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family

MRV Finlay, RJ Griffin - Bioorganic & medicinal chemistry letters, 2012 - Elsevier
Modulation of DNA repair pathways in oncology has been an area of intense interest in the
last decade, not least as a consequence of the promising clinical activity of poly (ADP …

ATR as a Therapeutic Target

FK Middleton, NJ Curtin - Advances in DNA Repair in Cancer Therapy, 2012 - Springer
Abstract Ataxia Telangiectasia Mutated and Rad3-related (ATR) is a vital sensor of a variety
of DNA lesions and is critical to cell cycle arrest at the S and G2 checkpoints as well as …